Literature DB >> 18504759

Comparison of three physiologically-based pharmacokinetic models for the prediction of contrast agent distribution measured by dynamic MR imaging.

Daniel P Barboriak1, James R MacFall, Benjamin L Viglianti, Mark W Dewhirst Dvm.   

Abstract

PURPOSE: To compare the performance of three physiologically-based pharmacokinetic (PBPK) models for predicting gadolinium contrast agent concentration-time curves (Gd-CTCs) obtained in superior sagittal sinus (SSS), cerebral cortex, and psoas muscle.
MATERIALS AND METHODS: Three published whole-body PBPK models were modified to predict Gd-CTCs in normal-appearing tissue. The models differed in the number of organs modeled and total number of compartments, and were designated as the "well-mixed," "delay," and "dispersion" models. The suitability of the three models to predict Gd-CTC was studied using data from dynamic contrast-enhanced MR perfusion imaging obtained at 1.5T from 10 patients with glioblastoma multiforme and at 3.0T from five patients with liver metastases.
RESULTS: The dispersion model produced better fits than the delay model in the SSS (P < 0.0001) and cerebral cortex (P < 0.0001), and better fits than the well-mixed model in psoas muscle (P < 0.005). No model produced better fits than the dispersion model at any of the three locations.
CONCLUSION: In this evaluation, the dispersion model was most robust for prediction of Gd-CTCs derived from dynamic contrast-enhanced (DCE)-MRI. This represents a preliminary step in the development of a PBPK model useful for predicting Gd-CTCs at a time resolution appropriate for dynamic MRI applications. 2008 Wiley-Liss, Inc

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18504759      PMCID: PMC3755278          DOI: 10.1002/jmri.21344

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  28 in total

1.  A whole-body physiologically based pharmacokinetic model incorporating dispersion concepts: short and long time characteristics.

Authors:  R E Oliver; A F Jones; M Rowland
Journal:  J Pharmacokinet Pharmacodyn       Date:  2001-02       Impact factor: 2.745

2.  Gd-DTPA relaxivity depends on macromolecular content.

Authors:  G J Stanisz; R M Henkelman
Journal:  Magn Reson Med       Date:  2000-11       Impact factor: 4.668

3.  Magnetic resonance imaging contrast-enhanced relaxometry of breast tumors: an MRI multicenter investigation concerning 100 patients.

Authors:  Pierre-Antoine Eliat; Véronique Dedieu; Catherine Bertino; Véronique Bouté; Joëlle Lacroix; Jean-Marc Constans; Brigitte de Korvin; Catherine Vincent; Corinne Bailly; Francis Joffre; Jacques de Certaines; Dominique Vincensini
Journal:  Magn Reson Imaging       Date:  2004-05       Impact factor: 2.546

Review 4.  The mean and standard deviation: what does it all mean?

Authors:  Edward H Livingston
Journal:  J Surg Res       Date:  2004-06-15       Impact factor: 2.192

5.  Musculoskeletal MRI at 3.0 T: relaxation times and image contrast.

Authors:  Garry E Gold; Eric Han; Jeff Stainsby; Graham Wright; Jean Brittain; Christopher Beaulieu
Journal:  AJR Am J Roentgenol       Date:  2004-08       Impact factor: 3.959

6.  Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts.

Authors:  P S Tofts; A G Kermode
Journal:  Magn Reson Med       Date:  1991-02       Impact factor: 4.668

7.  Pharmacokinetics of GdDTPA/dimeglumine after intravenous injection into healthy volunteers.

Authors:  H J Weinmann; M Laniado; W Mützel
Journal:  Physiol Chem Phys Med NMR       Date:  1984

8.  Model of the human vasculature for studying the influence of contrast injection speed on cerebral perfusion MRI.

Authors:  Matthias J P van Osch; Evert-Jan P A Vonken; Ona Wu; Max A Viergever; Jeroen van der Grond; Chris J G Bakker
Journal:  Magn Reson Med       Date:  2003-09       Impact factor: 4.668

9.  MRI estimation of the arterial input function in mice.

Authors:  Stephen Pickup; Rong Zhou; Jerry Glickson
Journal:  Acad Radiol       Date:  2003-09       Impact factor: 3.173

10.  The pharmacokinetics of the interstitial space in humans.

Authors:  David G Levitt
Journal:  BMC Clin Pharmacol       Date:  2003-07-30
View more
  17 in total

1.  BioDMET: a physiologically based pharmacokinetic simulation tool for assessing proposed solutions to complex biological problems.

Authors:  John F Graf; Bernhard J Scholz; Maria I Zavodszky
Journal:  J Pharmacokinet Pharmacodyn       Date:  2011-12-10       Impact factor: 2.745

Review 2.  Advanced magnetic resonance imaging of the physical processes in human glioblastoma.

Authors:  Jayashree Kalpathy-Cramer; Elizabeth R Gerstner; Kyrre E Emblem; Ovidiu Andronesi; Bruce Rosen
Journal:  Cancer Res       Date:  2014-09-01       Impact factor: 12.701

3.  Assessment of DCE-MRI parameters for brain tumors through implementation of physiologically-based pharmacokinetic model approaches for Gd-DOTA.

Authors:  Marios Spanakis; Eleftherios Kontopodis; Sophie Van Cauter; Vangelis Sakkalis; Kostas Marias
Journal:  J Pharmacokinet Pharmacodyn       Date:  2016-09-19       Impact factor: 2.745

Review 4.  Assessment of therapeutic response and treatment planning for brain tumors using metabolic and physiological MRI.

Authors:  Sarah J Nelson
Journal:  NMR Biomed       Date:  2011-04-27       Impact factor: 4.044

Review 5.  Advanced magnetic resonance imaging methods for planning and monitoring radiation therapy in patients with high-grade glioma.

Authors:  Janine M Lupo; Sarah J Nelson
Journal:  Semin Radiat Oncol       Date:  2014-07-26       Impact factor: 5.934

6.  Identifying the association between contrast enhancement pattern, surgical resection, and prognosis in anaplastic glioma patients.

Authors:  Yinyan Wang; Kai Wang; Jiangfei Wang; Shaowu Li; Jun Ma; Jianping Dai; Tao Jiang
Journal:  Neuroradiology       Date:  2016-01-21       Impact factor: 2.804

7.  PKQuest_Java: free, interactive physiologically based pharmacokinetic software package and tutorial.

Authors:  David G Levitt
Journal:  BMC Res Notes       Date:  2009-08-05

8.  Changes in vascular permeability and expression of different angiogenic factors following anti-angiogenic treatment in rat glioma.

Authors:  Meser M Ali; Branislava Janic; Abbas Babajani-Feremi; Nadimpalli R S Varma; A S M Iskander; John Anagli; Ali S Arbab
Journal:  PLoS One       Date:  2010-01-15       Impact factor: 3.240

9.  Delayed contrast extravasation MRI for depicting tumor and non-tumoral tissues in primary and metastatic brain tumors.

Authors:  Leor Zach; David Guez; David Last; Dianne Daniels; Yuval Grober; Ouzi Nissim; Chen Hoffmann; Dvora Nass; Alisa Talianski; Roberto Spiegelmann; Zvi R Cohen; Yael Mardor
Journal:  PLoS One       Date:  2012-12-14       Impact factor: 3.240

10.  Gadolinium-labeled affibody-XTEN recombinant vector for detection of HER2+ lesions of ovarian cancer lung metastasis using quantitative MRI.

Authors:  Alireza Nomani; Geng Li; Siavash Yousefi; Shawn Wu; Obeid M Malekshah; Shahryar K Nikkhoi; Mehrdad Pourfathi; Rahim Rizi; Arash Hatefi
Journal:  J Control Release       Date:  2021-07-18       Impact factor: 11.467

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.